4
Funding Rounds
$6.5m
Money raised
A digital fertility clinic offering semen analysis, sperm improvement, and sperm cryostorage services. Founded at Harvard in 2018, the company has raised $20M from investors like Y Combinator, Bain Capital Ventures, FirstMark Capital, and celebrities like Justin Bieber.
Industries:
Location:
Key people:
- Khaled Kteily ******@givelegacy.com
- Sarah Steinle *****@givelegacy.com
3
Funding Rounds
$60.0m
Money raised
Uncommon, formerly known as Higher Steaks, is a cellular agriculture company based in London, England founded in 2017 by Benjamina Bollag, Stephanie Wallis and David Hay working to develop pork and other meat products using cellular agriculture.
Industries:
Location:
Key people:
- Benjamina Bollag linkedin
- Stephanie Wallis *********.******@maticabio.com
- David Hay *****@uncommongoods.com
4
Funding Rounds
$49.3m
Money raised
Sphere Fluidics is a company commercializing single cell analysis systems founded in 2010 by Wilhelm Huck.
Industries:
Location:
Key people:
5
Funding Rounds
$10.1m
Money raised
A full-stack neural interface company. BIOS is creating a hardware and software interface between the human nervous system and AI with the aim of developing AI-based neural treatments that recreate neural signal patterns capable of affecting the health of a person.
Industries:
Location:
Key people:
3
Funding Rounds
$183.9m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
8
Funding Rounds
$160.3m
Money raised
Breathalyzer device maker for the early detection of cancer.
Industries:
Location:
Key people:
- Billy Boyle *****.*****@owlstone.co.uk
- David Ruiz Alonso *****.****@owlstone.co.uk
3
Funding Rounds
$133.0m
Money raised
Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.
Industries:
Location:
Key people:
- Michael Chen *****@nuclera.com
- Jiahao Huang ******@nuclera.com
- Gordon McInroy ******@nuclera.com
5
Funding Rounds
$30.9m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
10
Funding Rounds
$62.4m
Money raised
A software solutions company providing bioinformatics solutions to life science and other sector
Industries:
Location:
Key people:
6
Funding Rounds
$2.4m
Money raised
A company that has developed software for easier access to genomic data. It is located in Cambridge, England and was founded in 2015.
Industries:
Location:
Key people:
- Dan Greenfield ***@petagene.com
- Vaughan Wittorff *******@petagene.com
5
Funding Rounds
$65.4m
Money raised
An agricultural biotechnology company producing renewable, biomass-based fuels and raw materials
Industries:
Key people:
- Michael Raab (entrepreneur) *******.****@agrivida.com
11
Funding Rounds
$1.4b
Money raised
CMR Surgical is a surgical robotics solutions provider founded in 2014 by Martin Frost, Luke Hares and Mark Slack.
Industries:
Location:
Key people:
- Martin Frost ******.*****@hypervisionsurgical.com
- Mark Slack ****.*****@cmrsurgical.com
- Luke Hares ****.*****@cmrsurgical.com
4
Funding Rounds
$124.1m
Money raised
Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.
Industries:
Location:
Key people:
- David Brown *****.*****@healx.ai
- Tim Guilliams ***.*********@healx.ai
5
Funding Rounds
$187.0m
Money raised
Iterative Health is a Cambridge, Massachusetts-based company that provides gastroenterologists with machine learning-powered diagnostic tools to aid in the prevention of colon cancer and improve patient outcomes.
Industries:
Key people:
- Jonathan Ng (entrepreneur) ********.**@iterative.health
4
Funding Rounds
$68.1m
Money raised
Evonetix is a synthetic biology company
8
Funding Rounds
$84.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
Industries:
Location:
1
Funding Rounds
Isomerase is a Cambridge based microbial natural products drug discovery and development CRO and synthetic biology, fermentation and chemistry service provider
Industries:
Location:
Key people:
13
Funding Rounds
$123.5m
Money raised
CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.
Industries:
Location:
6
Funding Rounds
$52.4m
Money raised
Endomag is an Austin, Texas-based medical diagnostics company developing detection technology for lymphatic cancers.
Industries:
Location:
Key people:
- Quentin Pankhurst
- Audrius Brazdeikis ***********@endomag.com
- Simon Hattersley
4
Funding Rounds
$179.4m
Money raised
Kymab is a biopharmecutical company developing human antibody based therapies founded in 2010.
Industries:
Location:
4
Funding Rounds
$420.2m
Money raised
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
Industries:
Location:
3
Funding Rounds
$66.0m
Money raised
Mori manufactures an all-natural protective layer to slow down the spoiling process of food.
Industries:
Key people:
- Jacques Grislain *******@babymori.com
9
Funding Rounds
$110.7m
Money raised
Congenica clinical decision support software is the world's leading solution for the analysis of genomic data, enabling healthcare professionals globally.
Industries:
Location:
Key people:
- Eugene Bragin ******.******@congenica.com
- Thomas Weaver ******.******@congenica.com
6
Funding Rounds
$29.6m
Money raised
AI platform to advance precision medicine clinical trials.
Location:
Key people:
- Charlotte Guzzo *********@sanogenetics.com
- Patrick Short *******@sanogenetics.com
- William Jones ****@sanogenetics.com
4
Funding Rounds
$76.8m
Money raised
Provider of SITESEEKER platform for discovering new drugs.
Location:
Key people:
- Ashok Venkitaraman
- Chris Torrance *****.********@phoremost.com
5
Funding Rounds
$10.5m
Money raised
Definigen is a human Cell Models of Rare Diseases founded in 2012 by Marcus Yeo.
Industries:
Location:
Key people:
3
Funding Rounds
$77.0m
Money raised
PetMedix is a veterinary therapeutics biotechnology company based in Cambridge, UK. working to develop precision therapeutics to improve the health and welfare of pets.
5
Funding Rounds
$55.9m
Money raised
MetaMark Genetics is a medical diagnostics company developing tests and treatment planning for cancer patients.
Industries:
Key people:
- Ronald A. DePinho
- Kenneth E. Weg
- David Rimm *****.****@yale.edu
5
Funding Rounds
$94.3m
Money raised
Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.
Industries:
Key people:
3
Funding Rounds
$115.0m
Money raised
Platform for AI-driven drug discovery in clinical-stage development.
Industries:
Location:
Key people:
- Ivan Griffin ****.*******@benevolent.com
- Michael Brennan *******.*******@benevolent.com
4
Funding Rounds
$101.6m
Money raised
Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer
Industries:
Location:
2
Funding Rounds
$20.0m
Money raised
A company that provides services and technologies for the development and commercialization of biopharmaceutical products
Industries:
Location:
4
Funding Rounds
$166.8m
Money raised
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.
Industries:
Location:
4
Funding Rounds
$53.0m
Money raised
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.
Industries:
Key people:
- Bruce Booth ******@atlasventure.com
4
Funding Rounds
$22.5m
Money raised
Cambridge-based Genomics Company specializing in DNA sequencing technology
Industries:
Key people:
1
Funding Rounds
$40.6m
Money raised
Therapies designed to achieve long-term disease remission with less frequent doses.
Industries:
Location:
10
Funding Rounds
$27.8m
Money raised
A Cambridge UK based company focused on the development of technologies for single-molecule analysis
Industries:
Location:
Key people:
- Barnaby Balmforth *.*********@biofidelity.com
- Cameron Frayling *.********@biofidelity.com
4
Funding Rounds
$58.3m
Money raised
Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.
3
Funding Rounds
$88.0m
Money raised
Foldrx Pharmaceuticals is a company that develops disease modifying drug therapies.
Industries:
Key people:
1
Funding Rounds
$718.0k
Money raised
A company offering medicinal chemistry and computational chemistry services for drug dicovery
Industries:
3
Funding Rounds
$70.0m
Money raised
Biofidelity Ltd is a genetic Testing Technology founded in 2019 by Barnaby Balmforth.
Industries:
Location:
Key people:
- Cameron Frayling *.********@biofidelity.com
- Barnaby Balmforth *.*********@biofidelity.com
1
Funding Rounds
$1.6m
Money raised
Abcodia is a Cambridge, Cambridgeshire-based biotechnology company developing and validating molecular biomarkers for early cancer detection and other applications.
2
Funding Rounds
$8.2m
Money raised
CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
Location:
Key people:
- Namshik Han ****@cardiatec.ai
- Raphael Peralta ********@cardiatec.ai
- Thelma Zablocki *********@cardiatec.ai
2
Funding Rounds
$19.1m
Money raised
PredictImmune is a Cambridge, Cambridgeshire-based medical diagnostics company developing diagnostic products for addressing inflammatory bowel diseases.
Industries:
Location:
Key people:
1
Funding Rounds
$88.0m
Money raised
Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.
Industries:
Location:
Key people:
- Shankar Balasubramanian *******@biomodal.com
- Bobby Yerramilli-Rao *******@microsoft.com
3
Funding Rounds
$37.2m
Money raised
Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.
4
Funding Rounds
$23.2m
Money raised
Platform for increasing protein production in the body using specialized translation enhancers.
Industries:
Location:
2
Funding Rounds
$2.9m
Money raised
Platform utilizing microfabrication technology to create smart materials for innovative cell testing.
1
Funding Rounds
$600.0k
Money raised
Xenomics is advancing breakthroughs in genetics and biomanufacturing to combat major sustainability issues in food, energy, and health.
Industries:
Key people:
- Ryan Hubbard
- John Harrold
- David Preiner *****@xenomics.com
1
Funding Rounds
$3.5m
Money raised
Clinical Research IO is a clinical research company founded in 2015 by Phuc Truong.
Industries:
Key people:
- Raymond Nomizu *******@clinicalresearch.io
- Phuc Truong linkedin
2
Funding Rounds
$19.5m
Money raised
Resolvyx Pharmaceuticals is a company developing small molecule therapeutics for the treatment of inflammatory diseases
Industries:
Key people:
- Daniel Goodman ********@midtownpractice.com
1
Funding Rounds
$9.1m
Money raised
Supplant is a Cambridge, Cambridgeshire-based company founded in 2017 by Ruben Tadmor.
1
Funding Rounds
Intellegens is an artificial Intelligence company founded by Ben Pellegrini.
Industries:
Location:
Key people:
2
Funding Rounds
$40.4m
Money raised
Wren Therapeutics is a small Molecules Targeting Protein Mis-Folding founded in 2016 by Chris Dobson.
Industries:
Key people:
1
Funding Rounds
$16.0m
Money raised
Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.
Industries:
Location:
Key people:
- Daniel Ives ***@shiftbioscience.com
- Brendan Swain *******@shiftbioscience.com
2
Funding Rounds
$20.0m
Money raised
Charco Neurotech is a wearable device that offers non-invasive medical technology founded in 2019.
Industries:
Location:
3
Funding Rounds
$60.0m
Money raised
A biotechnology company developing therapies and personalized diagnostics for celiac disease
Industries:
Key people:
2
Funding Rounds
$88.0m
Money raised
Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.
Industries:
Location:
Key people:
- John McCafferty **@maxion.co.uk
- Aneesh Karatt Vellatt ***@maxion.co.uk
1
Funding Rounds
$4.2m
Money raised
Axol Bioscience Ltd is a human Cell Culture Products founded in 2012.
4
Funding Rounds
$47.8m
Money raised
NeoPhore is a small Molecules founded in 2017.
Industries:
Location:
2
Funding Rounds
$7.5m
Money raised
Contract Research Organization specializing in bioscience research services.
Industries:
Location:
Software solutions for small molecule design, optimization and data analysis
Industries:
Location:
1
Funding Rounds
$8.0m
Money raised
PlaqueTec is developing a Liquid Biopsy System, for the prevention, diagnosis and treatment of coronary artery disease.
Industries:
Location:
1
Funding Rounds
$22.0m
Money raised
A biopharmaceutical company developing drugs to treat pain, inflammation, anxiety and other diseases
Industries:
Key people:
1
Funding Rounds
$50.0m
Money raised
Transition Bio is a condensate technology, liquid-liquid phase separation founded by Peter St George-Hyslop.
Industries:
Key people:
2
Funding Rounds
$52.3m
Money raised
LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.
Industries:
Location:
Key people:
- Caroline Benn *****@loqus23.com
- David Reynolds *********@loqus23.com
1
Funding Rounds
$2.0m
Money raised
A company developing and offering open platform for industrial, academic and clinical scientists to develop and use multiplexed biological assays
Industries:
1
Funding Rounds
$24.0m
Money raised
A biopharmaceutical company that develops therapeutics for withdrawal symptoms, impulsivity, and cravings from smoking
Industries:
Location:
2
Funding Rounds
$7.5m
Money raised
Amphista Therapeutics Limited is a company founded in 2017 by Alessio Ciulli.